Moderna mRNA Technology

Moderna joins race for Ebola vaccine

Moderna CEPI Ebola Vaccine Work Highlights Broader Infectious Disease Ambitions

Moderna (NasdaqGS:MRNA) has expanded its collaboration with CEPI to accelerate development of an mRNA vaccine targeting Bundibugyo ebolavirus. The partnership focuses on responding to an ongoing Ebola outbreak in Central Africa,

· 1d

Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

MSN · 1d

Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

1don MSN

Moderna reports strong 5-year cancer vaccine data, expands CEPI partnership; stock falls

Moderna, Inc. MRNA stock is trading lower on Monday. The COVID-19 vaccine maker and Merck & Co Inc. MRK reported five-year ...

27don MSN

Moderna's mRNA flu vaccine is more effective than the standard shot in a late-stage trial

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, ...

10h

Moderna to Present at Upcoming Conference in June 2026

CAMBRIDGE, MA / ACCESS Newswire / June 2, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the ...

Time

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry

BioNTech co-founders Dr. Ugur Sahin and Dr. Ozlem Tureci in its headquarters in Germany on Jan. 3.Photograph by Dina Litovsky—Redux for TIME “No!” The doctor snapped. “Look at me!” I had been staring ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results